PL3890767T3 - Przeznaczone do inhalacji kompozycje do zastosowania w leczeniu chorób płuc - Google Patents

Przeznaczone do inhalacji kompozycje do zastosowania w leczeniu chorób płuc

Info

Publication number
PL3890767T3
PL3890767T3 PL19813329.0T PL19813329T PL3890767T3 PL 3890767 T3 PL3890767 T3 PL 3890767T3 PL 19813329 T PL19813329 T PL 19813329T PL 3890767 T3 PL3890767 T3 PL 3890767T3
Authority
PL
Poland
Prior art keywords
treatment
pulmonary diseases
inhalable compositions
inhalable
compositions
Prior art date
Application number
PL19813329.0T
Other languages
English (en)
Inventor
Oliver Denk
Original Assignee
Breath Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breath Therapeutics Gmbh filed Critical Breath Therapeutics Gmbh
Publication of PL3890767T3 publication Critical patent/PL3890767T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0018—Details of inhalators; Constructional features thereof with exhalation check valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19813329.0T 2018-12-04 2019-12-03 Przeznaczone do inhalacji kompozycje do zastosowania w leczeniu chorób płuc PL3890767T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18210255 2018-12-04
PCT/EP2019/083470 WO2020115032A1 (en) 2018-12-04 2019-12-03 Inhalable compositions for use in the treatment of pulmonary diseases

Publications (1)

Publication Number Publication Date
PL3890767T3 true PL3890767T3 (pl) 2023-05-08

Family

ID=64606777

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19813329.0T PL3890767T3 (pl) 2018-12-04 2019-12-03 Przeznaczone do inhalacji kompozycje do zastosowania w leczeniu chorób płuc

Country Status (22)

Country Link
US (3) US11419819B2 (pl)
EP (1) EP3890767B1 (pl)
JP (1) JP7285930B2 (pl)
KR (1) KR102475644B1 (pl)
CN (3) CN113164553B (pl)
AU (1) AU2019392626B2 (pl)
BR (1) BR112021010756A2 (pl)
CA (1) CA3121362C (pl)
CO (1) CO2021007141A2 (pl)
EA (2) EA202092892A1 (pl)
ES (1) ES2932966T3 (pl)
FI (1) FI3890767T3 (pl)
HR (1) HRP20221529T1 (pl)
HU (1) HUE060322T2 (pl)
IL (1) IL283469B (pl)
LT (1) LT3890767T (pl)
MX (1) MX2021006585A (pl)
PL (1) PL3890767T3 (pl)
PT (1) PT3890767T (pl)
RS (1) RS63847B1 (pl)
SI (1) SI3890767T1 (pl)
WO (1) WO2020115032A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069711A1 (en) * 2015-03-16 2016-09-21 PARI Pharma GmbH Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
EP4249022A1 (en) * 2022-03-21 2023-09-27 PARI Pharma GmbH Drug-device combination
CN115006656A (zh) * 2022-05-18 2022-09-06 苏州易合医药有限公司 一种可连续提供肺部活性剂粉雾剂的给药装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857319A (en) 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5958378A (en) 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
TW497974B (en) 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
IT1289938B1 (it) 1997-02-20 1998-10-19 Angelini Ricerche Spa Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
WO2000027455A1 (en) * 1998-11-06 2000-05-18 Salter Labs Nebulizer mouthpiece and accessories
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
DE10102846B4 (de) 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US7452524B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
US20060110441A1 (en) * 2004-10-28 2006-05-25 Harry Wong Lyophilized liposome formulations and method
DE102005038619A1 (de) 2005-08-16 2007-02-22 Pari GmbH Spezialisten für effektive Inhalation Inhalationstherapievorrichtung mit einer Ampulle für die Bevorratung eines zu vernebelnden Medikaments
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
WO2007067784A2 (en) 2005-12-08 2007-06-14 Wyeth Liposomal compositions
EP1927373B1 (en) 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
ES2452935T3 (es) * 2008-04-04 2014-04-03 Nektar Therapeutics Dispositivo de aerosolización
EP2608829A4 (en) 2010-08-23 2015-11-18 Darren Rubin SYSTEMS AND METHODS FOR AEROSOL SUPPLY WITH AIRFLOW REGULATION
US9719184B2 (en) * 2010-12-28 2017-08-01 Stamford Devices Ltd. Photodefined aperture plate and method for producing the same
HRP20220158T1 (hr) * 2012-05-21 2022-04-15 Insmed Incorporated Sustavi za liječenje plućnih infekcija
US9677919B2 (en) * 2014-11-26 2017-06-13 Rosemount Inc. Gauge display system
EP3069711A1 (en) 2015-03-16 2016-09-21 PARI Pharma GmbH Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
US9566399B1 (en) * 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery

Also Published As

Publication number Publication date
EP3890767A1 (en) 2021-10-13
IL283469B (en) 2022-07-01
BR112021010756A2 (pt) 2021-08-31
MX2021006585A (es) 2022-07-04
PT3890767T (pt) 2022-11-29
AU2019392626B2 (en) 2022-02-10
CA3121362C (en) 2024-01-02
CN113164553B (zh) 2023-04-21
CA3121362A1 (en) 2020-06-11
EA202191307A1 (ru) 2021-08-09
CN116726146A (zh) 2023-09-12
AU2019392626A1 (en) 2021-06-24
US20220347098A1 (en) 2022-11-03
CN116688093A (zh) 2023-09-05
FI3890767T3 (fi) 2023-01-13
LT3890767T (lt) 2022-12-12
JP2022510953A (ja) 2022-01-28
CN113164553A (zh) 2021-07-23
KR20210110312A (ko) 2021-09-07
HRP20221529T1 (hr) 2023-02-17
WO2020115032A1 (en) 2020-06-11
RS63847B1 (sr) 2023-01-31
IL283469A (en) 2021-07-29
US11890376B2 (en) 2024-02-06
US20220023211A1 (en) 2022-01-27
US20240122852A1 (en) 2024-04-18
JP7285930B2 (ja) 2023-06-02
ES2932966T3 (es) 2023-01-30
CO2021007141A2 (es) 2021-08-19
SI3890767T1 (sl) 2023-02-28
US11419819B2 (en) 2022-08-23
EP3890767B1 (en) 2022-10-12
EA202092892A1 (ru) 2021-05-27
HUE060322T2 (hu) 2023-02-28
KR102475644B1 (ko) 2022-12-07

Similar Documents

Publication Publication Date Title
IL283840A (en) Preparations for administering therapeutic substances and methods for their use and preparation
EP3349783C0 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES
HUE049237T2 (hu) Készítmények a bõr sérülései, rendellenességei és betegségei kezelési eljárásaiban történõ alkalmazásra
IL267210A (en) Amino acid compounds and methods for treating muscle diseases and disorders
EP3337465A4 (en) Compositions and methods of use in combination for the treatment and diagnosis of autoimmune diseases
IL283469A (en) Inhalable preparations for use in the treatment of lung diseases
IL272314A (en) Use of inhaled nitrous oxide to treat pulmonary hypertension associated with lung disease
IL278079A (en) Inhalable liposomal sustained release compound for use in the treatment of pulmonary disease
IL274578A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
SG11201912103TA (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
IL287796A (en) Preparations and methods for the treatment of diseases mediated by ATPase
IL284125A (en) History of quinoline for use in the treatment of inflammatory diseases
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
IL272495A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
PL3515409T3 (pl) Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych
SG11201912098SA (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease
JP2018536642A5 (ja) 小関節窩の置換および／もしくは再生における使用のための、および／もしくは、椎間関節の疾患の予防および／もしくは治療における使用のための、医療用組成物及び医療用ヒドロゲル
GB201817346D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of diseases
GB201718838D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
GB201712742D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
IL254140A0 (en) Preparations and combinations for use in the treatment of angiogenic diseases and disorders
GB201603510D0 (en) Compositions for use in the treatment of neurological disease
IL243402A0 (en) Methods for identifying preparations for use in the treatment of heart diseases and the use of preparations for the treatment of these diseases